Skip to content
2000
Volume 22, Issue 6
  • ISSN: 1871-5273
  • E-ISSN: 1996-3181

Abstract

Coronavirus disease 2019 (COVID-19) is a primary respiratory disease with an alarming impact worldwide. COVID-19 is caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) and presents various neurological symptoms, including seizures. SARS-CoV-2 shows neuroinvasive and neurotropic capabilities through a neuronal angiotensin-converting enzyme 2 (ACE2), which is also highly expressed in both neuronal and glial cells. Therefore, SARS-CoV-2 can trigger neuroinflammation and neuronal hyperexcitability, increasing the risk of seizures. Olfactory neurons could be an exceptional neuronal pathway for the neuroinvasion of respiratory viruses to access the central nervous system (CNS) from the nasal cavity, leading to neuronal injury and neuroinflammation. Although neuronal ACE2 has been widely studied, other receptors for SARS-CoV-2 in the brain have been proposed to mediate viral-neuronal interactions with subsequent neurological squeals. Thus, the objective of the present critical review was to find the association and mechanistic insight between COVID-19 and the risk of seizures.

Loading

Article metrics loading...

/content/journals/cnsnddt/10.2174/1871527321666220517115227
2023-07-01
2025-09-10
Loading full text...

Full text loading...

/content/journals/cnsnddt/10.2174/1871527321666220517115227
Loading

  • Article Type:
    Review Article
Keyword(s): ALI; ARDS; cytokine storm; epilepsy; SARS-CoV-2; seizure
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test